Taken together, these results suggested that the HIF-1α antagonist alleviated the pathological symptoms of MCT-induced PAH-like rats by regulating fatty acid uptake via CD36 and the Parkin/PINK1 signaling pathway. The gene discussed is HIF1A; the disease is pulmonary arterial hypertension.